% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Galuschka:124256,
author = {C. Galuschka$^*$ and R. Proynova$^*$ and B. Roth$^*$ and H.
Augustin$^*$ and K. Müller-Decker$^*$},
title = {{M}odels in {T}ranslational {O}ncology: {A} {P}ublic
{R}esource {D}atabase for {P}reclinical {C}ancer
{R}esearch.},
journal = {Cancer research},
volume = {77},
number = {10},
issn = {1538-7445},
address = {Philadelphia, Pa.},
publisher = {AACR},
reportid = {DKFZ-2017-01152},
pages = {2557 - 2563},
year = {2017},
abstract = {The devastating diseases of human cancer are mimicked in
basic and translational cancer research by a steadily
increasing number of tumor models, a situation requiring a
platform with standardized reports to share model data.
Models in Translational Oncology (MiTO) database was
developed as a unique Web platform aiming for a
comprehensive overview of preclinical models covering
genetically engineered organisms, models of transplantation,
chemical/physical induction, or spontaneous development,
reviewed here. MiTO serves data entry for metastasis
profiles and interventions. Moreover, cell lines and animal
lines including tool strains can be recorded. Hyperlinks for
connection with other databases and file uploads as
supplementary information are supported. Several
communication tools are offered to facilitate exchange of
information. Notably, intellectual property can be protected
prior to publication by inventor-defined accessibility of
any given model. Data recall is via a highly configurable
keyword search. Genome editing is expected to result in
changes of the spectrum of model organisms, a reason to open
MiTO for species-independent data. Registered users may
deposit own model fact sheets (FS). MiTO experts check them
for plausibility. Independently, manually curated FS are
provided to principle investigators for revision and
publication. Importantly, noneditable versions of reviewed
FS can be cited in peer-reviewed journals. Cancer Res;
77(10); 2557-63. ©2017 AACR.},
subtyp = {Review Article},
cin = {A190 / W420 / W310 / G230 / L101},
ddc = {610},
cid = {I:(DE-He78)A190-20160331 / I:(DE-He78)W420-20160331 /
I:(DE-He78)W310-20160331 / I:(DE-He78)G230-20160331 /
I:(DE-He78)L101-20160331},
pnm = {311 - Signalling pathways, cell and tumor biology
(POF3-311)},
pid = {G:(DE-HGF)POF3-311},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:28507049},
doi = {10.1158/0008-5472.CAN-16-3099},
url = {https://inrepo02.dkfz.de/record/124256},
}